Corcept Therapeutics' GAAP net income for 2020 was $106.011 million, up 12.6% from $94.181 million in the previous year. Revenue increased 15.5% to $353.874 million from $306.486 million a year earlier.
Corcept Therapeutics' GAAP net income for 2020 was $106.011 million, up 12.6% from $94.181 million in the previous year. Revenue increased 15.5% to $353.874 million from $306.486 million a year earlier. 
ir.corcept.com
English (US) 